Persistent Fatigue Prevalent After COVID-19 Infection
For individuals who have recovered from the acute phase of COVID-19, postviral fatigue is prevalent and is not associated with COVID-19 severity.
Neurology Information Center
Neuropathological Changes in Autopsied Brain Tissue of Patients With COVID-19
Neuropathological changes in patients with coronavirus disease 2019 are relatively mild, with neuroinflammatory changes in the brain stem most often found.
Long-Term Outcomes of New Onset Super Refractory Status Epilepticus
Study findings present 71% of patients with new-onset super refractory status epilepticus as having good or fair outcomes at long-term follow-up.
Microglial Activity During the Hyperacute Phase of Ischemic Stroke
Calcium activity was detected in microglia calcium during the hyperacute phase of ischemic stroke.
Update on Alzheimer Dementia Spectrum: Diagnosis and Management
Although the cause of Alzheimer disease is not clear, recent advances in research have furthered the understanding of Alzheimer dementia as a continuum.
Alterations of Sleep Patterns at the Family Level During Home Confinement Due to COVID-19
This study addresses possible consequences of the COVID-19 crisis and home confinement on maternal anxiety, maternal insomnia, and maternal reports of sleep problems among children aged 6–72 months.
Risk of Stroke in Hospitalized SARS-CoV-2 Patients: A Meta-Analysis
Study authors conducted a multinational meta-analysis in SARS-CoV-2 patients to assess the risk of stroke relative to the general population and to identify risk factors of stroke.
FDA Rejects Qtrypta NDA for Acute Treatment of Migraine
Qtrypta delivers zolmitriptan, a selective 5-HT1B/1D receptor agonist, using the Company’s proprietary Adhesive Dermally-Applied Microarray (ADAM) technology that consists of a drug-coated microneedle patch.
Physical Activity, Sleep Profiles Vary in Adults With Arthritis
Four distinct physical activity profiles are detectable using activity monitoring among adults with arthritis.
Insufficient and Excessive Sleep Associated With Faster Cognitive Decline
Both insufficient and excessive sleep are associated with faster cognitive decline compared with sleeping approximately 7 hours per night.
Evaluating Intramuscular Pressure Among Patients With Fibromyalgia
Researchers sought to evaluate the level of muscle tenderness and intramuscular pressure in the trapezius muscle of patients with fibromyalgia syndrome in comparison to controls.
Adolescents Not Receiving Guidance From Primary Care Providers on Adult Health Care
Research conducted by the CDC concludes that the majority of adolescents, especially those aged 12 to 14 years, are not receiving comprehensive health care transition planning by their primary care provider.
Safety and Efficacy of Antidepressants in Menopausal Sleep Disturbances
Serotonergic antidepressants are effective for sleep disturbances in perimenopausal and postmenopausal women even without major depressive disorder.
Fibromyalgia in Psoriatic Arthritis Associated With Sleep Disturbances and Poor Quality of Life
Researchers evaluated the association between fibromyalgia in psoriatic arthritis and enthesopathy, sleep, fatigue, and quality of life.
Study Evaluates Plasma Biomarkers for Sports-Related Concussion
Researchers conducted a study to examine whether plasma biomarkers can differentiate collegiate athletes who return to sports participation in less than 14 days or 14 days or more following a sports-related concussion.
Comorbid ADHD More Prevalent in Boys, Adolescents With Autism Spectrum Disorder
A retrospective study was conducted to evaluate the demographic predictors of ADHD in hospitalized children with ASD and the impact of comorbidities on length of stay.
USPSTF: Evidence Lacking for Screening Elders for Hearing Loss
The USPSTF concludes that evidence is inadequate for assessing the balance of benefits and harms of hearing loss screening for older adults.
Solriamfetol Improves Driving Performance in Patients With Excessive Daytime Sleepiness and Obstructive Sleep Apnea
Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
Fremanezumab Found to Reduce Number of Migraine Days in Patients With Chronic Migraine and Comorbid Depression
A pooled analysis evaluated reductions in migraine and headache days among patients with chronic migraine and comorbid depression in 2 placebo-controlled, phase 3 trials of fremanezumab.
Novel Stimulant Effective for Adult ADHD, Regardless of Prior Stimulant Exposure
SHP465 mixed amphetamine salts reduced symptoms of attention-deficit/hyperactivity disorder in adults, independent of ADHD treatment history.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Neurology Information Center
